AAAAAA

   
Results: 1-12 |
Results: 12
CONTINUOUS DELIVERY OF HUMAN AND MOUSE ERYTHROPOIETIN IN MICE BY GENETICALLY-ENGINEERED POLYMER ENCAPSULATED MYOBLASTS
Authors: REGULIER E SCHNEIDER BL DEGLON N BEUZARD Y AEBISCHER P
Citation: E. Regulier et al., CONTINUOUS DELIVERY OF HUMAN AND MOUSE ERYTHROPOIETIN IN MICE BY GENETICALLY-ENGINEERED POLYMER ENCAPSULATED MYOBLASTS, Gene therapy, 5(8), 1998, pp. 1014-1022
A GENE-THERAPY APPROACH TO REGULATED DELIVERY OF ERYTHROPOIETIN AS A FUNCTION OF OXYGEN-TENSION
Authors: RINSCH C REGULIER E DEGLON N DALLE B BEUZARD Y AEBISCHER P
Citation: C. Rinsch et al., A GENE-THERAPY APPROACH TO REGULATED DELIVERY OF ERYTHROPOIETIN AS A FUNCTION OF OXYGEN-TENSION, Human gene therapy, 8(16), 1997, pp. 1881-1889
INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS (VOL 2, PG 696, 1996)
Authors: AEBISCHER P SCHLUEP M DEGLON N JOSEPH JM HIRT L HEYD B GODDARD M HAMMANG JP ZURN AD KATO AC REGLI F BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS (VOL 2, PG 696, 1996), Nature medicine, 2(9), 1996, pp. 1041-1041
INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS
Authors: AEBISCHER P SCHLUEP M DEGLON N JOSEPH JM HIRT L HEYD B GODDARD M HAMMANG JP ZURN AD KATO AC REGLI F BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS, Nature medicine, 2(6), 1996, pp. 696-699
GENE-THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) USING A POLYMER ENCAPSULATED XENOGENIC CELL-LINE ENGINEERED TO SECRETE HCNTF
Authors: AEBISCHER P POCHON NAM HEYD B DEGLON N JOSEPH JM ZURN AD BAETGE EE HAMMANG JP GODDARD M LYSAGHT M KAPLAN F KATO AC SCHLUEP M HIRT L REGLI F PORCHET F DETRIBOLET N
Citation: P. Aebischer et al., GENE-THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) USING A POLYMER ENCAPSULATED XENOGENIC CELL-LINE ENGINEERED TO SECRETE HCNTF, Human gene therapy, 7(7), 1996, pp. 851-860
CENTRAL-NERVOUS-SYSTEM DELIVERY OF RECOMBINANT CILIARY NEUROTROPHIC FACTOR BY POLYMER ENCAPSULATED DIFFERENTIATED C2C12 MYOBLASTS
Authors: DEGLON N HEYD B TAN SA JOSEPH JM ZURN AD AEBISCHER P
Citation: N. Deglon et al., CENTRAL-NERVOUS-SYSTEM DELIVERY OF RECOMBINANT CILIARY NEUROTROPHIC FACTOR BY POLYMER ENCAPSULATED DIFFERENTIATED C2C12 MYOBLASTS, Human gene therapy, 7(17), 1996, pp. 2135-2146
RESCUE OF MOTONEURONS FROM AXOTOMY-INDUCED CELL-DEATH BY POLYMER ENCAPSULATED CELLS GENETICALLY-ENGINEERED TO RELEASE CNTF
Authors: TAN SA DEGLON N ZURN AD BAETGE EE BAMBER B KATO AC AEBISCHER P
Citation: Sa. Tan et al., RESCUE OF MOTONEURONS FROM AXOTOMY-INDUCED CELL-DEATH BY POLYMER ENCAPSULATED CELLS GENETICALLY-ENGINEERED TO RELEASE CNTF, Cell transplantation, 5(5), 1996, pp. 577-587
A GENE-THERAPY APPROACH FOR AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: ZURN AD DEGLON N JOSEPH JM AEBISCHER P
Citation: Ad. Zurn et al., A GENE-THERAPY APPROACH FOR AMYOTROPHIC-LATERAL-SCLEROSIS, Journal of neurochemistry, 66, 1996, pp. 7-7
ENCAPSULATION OF NEUROTROPHIC FACTOR-RELEASING CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
Authors: AEBISCHER P TAN SA DEGLON N HEYD B ZURN A BAETGE E SAGOT Y KATO A
Citation: P. Aebischer et al., ENCAPSULATION OF NEUROTROPHIC FACTOR-RELEASING CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, Restorative neurology and neuroscience, 8(1-2), 1995, pp. 65-66
ENCAPSULATION OF CNTF-RELEASING CELLS FOR THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: AEBISCHER P TAN SA DEGLON N HEYD B ZURN A BAETGE E SAGOT Y KATO A
Citation: P. Aebischer et al., ENCAPSULATION OF CNTF-RELEASING CELLS FOR THE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS, Journal of cellular biochemistry, 1995, pp. 2-2
FATTY-ACIDS REGULATE THY-1 ANTIGEN MESSENGER-RNA STABILITY IN T-LYMPHOCYTE PRECURSORS
Authors: DEGLON N WILSON A DESPONDS C LAURENT P BRON C FASEL N
Citation: N. Deglon et al., FATTY-ACIDS REGULATE THY-1 ANTIGEN MESSENGER-RNA STABILITY IN T-LYMPHOCYTE PRECURSORS, European journal of biochemistry, 231(3), 1995, pp. 687-696
MINIMAL MEMBRANE AND SECRETED MU-POLY(A) SIGNALS SPECIFY DEVELOPMENTALLY-REGULATED IMMUNOGLOBULIN HEAVY-CHAIN MESSENGER-RNA RATIOS WITHOUT RNA SPLICING
Authors: FASEL NJ DEGLON N BEGHDADIRAIS C LAW R BRON C WALL R
Citation: Nj. Fasel et al., MINIMAL MEMBRANE AND SECRETED MU-POLY(A) SIGNALS SPECIFY DEVELOPMENTALLY-REGULATED IMMUNOGLOBULIN HEAVY-CHAIN MESSENGER-RNA RATIOS WITHOUT RNA SPLICING, Molecular immunology, 31(7), 1994, pp. 563-566
Risultati: 1-12 |